about
Inflammation in depression: is adiposity a cause?Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptorsCSF and blood oxytocin concentration changes following intranasal delivery in macaqueThe effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating.Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible TreatmentOxytocin protects against negative behavioral and autonomic consequences of long-term social isolationOxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neuronsComponents of the basal lamina and dystrophin-dystroglycan complex in the neurointermediate lobe of rat pituitary gland: different localizations of beta-dystroglycan, dystrobrevins, alpha1-syntrophin, and aquaporin-4.Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders.Brainpeps: the blood-brain barrier peptide database.Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the ratSequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.Lack of association between human plasma oxytocin and interpersonal trust in a Prisoner's Dilemma paradigm.Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugsOxytocin facilitates female sexual maturation through a glia-to-neuron signaling pathwayDevelopmental exposure to vasopressin increases aggression in adult prairie voles.Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids.Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.Anxiolytic drug discovery: what are the novel approaches and how can we improve them?TRH and diseases of the motor system.Is oxytocin a maternal-foetal signalling molecule at birth? Implications for development.Oxytocin for the treatment of drug and alcohol use disorders.Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema.Functional role of intrahypothalamic release of oxytocin and vasopressin: consequences and controversies.Blood-brain transfer of L-phenylalanine declines after peripheral but not central nervous administration of vasopressin.Saturable retention of vasopressin by hippocampus vessels in vivo, associated with inhibition of blood-brain transfer of large neutral amino acids.Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs.Oxytocin and social functioning.Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.Sex differences and developmental effects of manipulations of oxytocin on alloparenting and anxiety in prairie voles.Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.Twenty-one hormones fail to inhibit the brain to blood transport system for Tyr-MIF-1 and the enkephalins in mice.Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier.Push-pull perfusion and microdialysis studies of central oxytocin and vasopressin release in freely moving rats during pregnancy, parturition, and lactation.Release of oxytocin into blood and into cerebrospinal fluid induced by naloxone in anaesthetized morphine-dependent rats: the role of the paraventricular nucleus.Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress.
P2860
Q24635451-C5670D9F-EF1C-4708-94DB-4A04C6E542DBQ24685616-2C603DD5-3450-4F53-B3E7-FB09A9676EF1Q28542031-A3C6BEDF-9745-4720-8115-488F0C789504Q30427738-0B0A382C-319A-47A5-80C1-92AA2C183BFCQ33664227-35232F51-7BD8-4E70-B2DF-29DB6B18B115Q33737859-50BEC6B5-B931-4D97-8FAA-1E0F0093D587Q33746858-B2ADFFAD-03F8-4C0E-8268-5186A4C46BAAQ33803160-40CABDF2-D398-43D8-987C-36B816D4C726Q34190355-1B78DB54-A2C7-4D70-B9B7-94788B9BB065Q34243408-3645949F-D3E6-4E2C-850C-76F52FC27258Q34254106-A5A025D1-0AE9-40A5-AEBC-D66822AF9DBDQ34293377-08335684-F155-40D6-8115-20EDB1CF00ACQ34790247-DC2E781F-01C1-44FE-BA67-4EECF050C039Q35243257-195DFB02-E4EC-487D-864F-0D955A9AC98CQ36509820-088AC45E-6656-4F82-B049-5AB1E7DA96FDQ36547508-49371C48-1B2E-47B1-B019-798804BB8DCEQ36588279-FC7D9F03-B458-43C0-AE1D-80EE9C76B2D3Q36793614-059DB0AA-404D-4748-AFC6-BC95F0569DF5Q36968903-81619E60-0321-45C6-AE90-26A81527A7E6Q38160918-2C58CE97-86AB-481C-A5BA-6A6C18A84F37Q38224466-84604737-DDE1-4593-8D02-5323B2221190Q38233628-920F8195-9B72-4B65-8C3D-E0996E083E5EQ38948516-BB5A9578-941C-4698-8D9F-8D48A2FA665EQ39257824-A5C88424-BCAB-4EBE-A7D3-2345C97A6E55Q40515394-70515201-CD93-4B88-AF64-5CBE8D31DC6DQ41208691-2F28B2D6-4334-41C0-9992-FDC9B7A09D7CQ41356648-909ED56F-2CC7-4E04-A904-C2D512DB02C3Q41453099-5F3258CF-0664-405D-8BB1-E86E8210B933Q41535736-DC9CE97F-A517-423C-B318-2D5217BA5C82Q43663162-55F7DEDA-9A96-4137-89DE-853E40EDB5A2Q44782663-99A6E72F-2406-4D87-A91B-57B6B78063EEQ47777382-E464A38D-6080-4F19-9AEE-CAB87C6FA01DQ48095901-391690C8-16BB-4B53-9A9B-0765491EBB34Q48233735-B53E0E60-108A-4995-ACB6-9BD7FEE82D87Q48241067-BFA5D598-3C2D-4155-8DE1-FC2B4CD390F3Q48468905-FDC8A11F-B9F3-48BA-B5B6-EF03CF32B0F0Q51704492-D8FAF9DB-29AA-4999-B2C3-F23C919EDD7FQ54970468-C6030160-0989-4FB0-9DF1-8C1181ADE707
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Blood-brain barrier and peptides.
@en
Blood-brain barrier and peptides.
@nl
type
label
Blood-brain barrier and peptides.
@en
Blood-brain barrier and peptides.
@nl
prefLabel
Blood-brain barrier and peptides.
@en
Blood-brain barrier and peptides.
@nl
P2093
P356
P1476
Blood-brain barrier and peptides.
@en
P2093
P304
P356
10.1038/JCBFM.1985.49
P577
1985-09-01T00:00:00Z